Hepatic failure and jaundice: Hepatic failure accompany with increasing AST, ALT, y-GTP, ALP rarely and jaundice may occur. If observed, discontinue the medicine and treatment.
Others: Hypersensitivity: Hives and rarely rash, pruritus, drug exanthema eczema etc may occur. If observed, discontinue medicine and treat.
CNS: Paralysis, dizziness, sleepiness may occur.
GI: Thirst and rarely constipation, abdominal distension diarrhea, nausea, vomiting, heartburn, stomachache, belching, dysgeusia may occur.
Hepatic: Increasing markedly aminotransferase such as AST, ALT, y-GTP, ALP, fever and jaundice may occur. If observed, discontinue the medicine and treatment.
Blood: Decreasing platelets and rarely white blood cell fractionation, decreasing segmented leukocyte, increasing lymphocyte, rarely, decreasing white blood cell and granulocyte may occur.
Others: Mammary swelling, mastalgia, gynecomastia, lactation, palpitation, fever, hot flush, tongue paralysis, cough, dyspnea, alopecia or rarely menstrual disorder, BUN increase, edema, globus pharynges etc may occur.
View ADR Monitoring Form